Microscopic Polyangiitis
📧 Sign up to get email alerts when something new happens for Microscopic Polyangiitis.
Sign up freeTop drugs studied for this disease
-
EMA trial_result · 2026-01-30EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA
The EMA has started a review of Tavneos (avacopan) after questions were raised about the integrity of data from the main pivotal study in gr…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]
A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: One-Time DNA Study for Vasculitis
A University of Pennsylvania-led trial is recruiting for a one-time DNA study of various vasculitides, including eosinophilic granulomatosis…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator
A completed clinical trial comparing rituximab biosimilars to the originator in ANCA-associated vasculitis, including granulomatosis with po…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Efficacy Study of Two Treatments in the Remission of Vasculitis [Phase 3]
Phase 3 trial update evaluating two treatments for inducing remission in granulomatosis with polyangiitis and microscopic polyangiitis; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) [Phase 3]
A Phase 3 trial evaluated adding azathioprine to corticosteroids in microscopic polyangiitis, polyarteritis nodosa, or eosinophilic granulom…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis [Phase 3]
Phase 3 trial comparing two rituximab regimens for maintaining or achieving remission in ANCA-associated vasculitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) [Phase 3]
Phase 3 trial evaluating mycophenolate mofetil for relapses of granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic p…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: PR3-AAV Resilient Remission or PRRR [Phase 2]
A Phase 2 trial of PR3-AAV Resilient Remission (PRRR) for ANCA-associated vasculitis, including granulomatosis with polyangiitis and microsc…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Hydroxychloroquine in ANCA Vasculitis Evaluation [Phase 4]
Phase 4 trial update evaluating hydroxychloroquine for ANCA-associated vasculitis, including microscopic polyangiitis, eosinophilic granulom…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis [Phase 3]
A Phase 3 trial evaluating rituximab for good prognosis microscopic polyangiitis is reported with efficacy and safety data being collected, …
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis [Phase 3]
Phase 3 trial of avacopan (CCX168) in ANCA-associated vasculitis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 2]
Phase 2 clinical trial updating the use of IFX-1 as an alternative to steroids in Granulomatosis with Polyangiitis and Microscopic Polyangii…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis [Phase 4]
Phase 4 trial evaluating safety and efficacy of rituximab combined with glucocorticoids in Wegener's Granulomatosis (granulomatosis with pol…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA [Phase 2]
Phase 2 safety and efficacy study of IFX-1 add-on to standard of care in GPA and MPA was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Rituximab Vasculitis Maintenance Study [Phase 3]
Phase 3 clinical trial update for rituximab maintenance in ANCA-associated vasculitis, including microscopic polyangiitis and Wegener granul…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Low-dose Glucocorticoid Vasculitis Induction Study [Phase 4]
Phase 4 clinical trial update investigating low-dose glucocorticoids for induction in vasculitis conditions.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis [Phase 3]
Phase 3 trial updating the use of plasma exchange and glucocorticoids for ANCA-associated vasculitis, with completion and results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis [Phase 2]
Phase IIa study evaluating intravenous rituximab in pediatric participants with granulomatosis with polyangiitis or microscopic polyangiitis…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis [Phase 4]
A Phase 4 pilot study evaluating short-course glucocorticoids plus rituximab for ANCA-associated vasculitis has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
This clinical trial update reports long-term follow-up results from the RAVE study evaluating rituximab for ANCA-associated vasculitis, incl…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: The ANCA Vasculitis Questionnaire (AAV-PRO©)
The ANCA Vasculitis Questionnaire (AAV-PRO©) trial update notes that the study evaluating a patient-reported outcome instrument for ANCA-ass…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
An observational safety study evaluated rituximab (MabThera/Rituxan) in granulomatosis with polyangiitis and microscopic polyangiitis. The s…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.